Tab 625 mg/Powd for oral susp 125 mg/31.25 mg/Powd for oral susp 250 mg/62.5 mg/Powd for oral susp 400 mg/57 mg: Amoxicillin and Clavulanic Acid is used for actinomycosis, anthrax, biliary tract infections, bronchitis, endocarditis (particularly prophylaxis), gastroenteritis (including salmonella enteritis), gonorrhea, Lyme disease mouth infections, otitis media, pneumonia, spleen disorders, pneumococcal infections prophylaxis, typhoid & paratyphoid fever and urinary tract infections.
Tab 1 g: Co-Amoxiclav is Indicated for the treatment of following infections caused by susceptible pathogens: Lower respiratory tract infections, acute otitis media, sinusitis, urinary tract infections, skin and soft tissue infections.
Co-Amoxiclav is also indicated for bacterial infections likely to be caused by amoxicillin-resistant beta-lactamase producing strains and that treatment should not usually exceed 14 days.
It is also considered for the following indications: Recurrent tonsilitis.
Acute exacerbations of chronic bronchitis, bronchopneumonia.
Urinary tract infection especially recurrent & complicated but not prostatitis.
Septic abortion, pelvic or puerperal sepsis & intra-abdominal sepsis.
Cellulitis, animal bites & severe dental abscess with spreading cellulitis.
Other Services
Country
Account